182 related articles for article (PubMed ID: 12808440)
1. Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer.
Ortiz-Urda S; Lin Q; Yant SR; Keene D; Kay MA; Khavari PA
Gene Ther; 2003 Jul; 10(13):1099-104. PubMed ID: 12808440
[TBL] [Abstract][Full Text] [Related]
2. PhiC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa.
Ortiz-Urda S; Thyagarajan B; Keene DR; Lin Q; Calos MP; Khavari PA
Hum Gene Ther; 2003 Jun; 14(9):923-8. PubMed ID: 12828862
[TBL] [Abstract][Full Text] [Related]
3. Stable nonviral genetic correction of inherited human skin disease.
Ortiz-Urda S; Thyagarajan B; Keene DR; Lin Q; Fang M; Calos MP; Khavari PA
Nat Med; 2002 Oct; 8(10):1166-70. PubMed ID: 12244305
[TBL] [Abstract][Full Text] [Related]
4. Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia.
Vailly J; Gagnoux-Palacios L; Dell'Ambra E; Roméro C; Pinola M; Zambruno G; De Luca M; Ortonne JP; Meneguzzi G
Gene Ther; 1998 Oct; 5(10):1322-32. PubMed ID: 9930337
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease.
Mühle C; Neuner A; Park J; Pacho F; Jiang Q; Waddington SN; Schneider H
Gene Ther; 2006 Dec; 13(23):1665-76. PubMed ID: 16871230
[TBL] [Abstract][Full Text] [Related]
6. Herlitz junctional epidermolysis bullosa.
Laimer M; Lanschuetzer CM; Diem A; Bauer JW
Dermatol Clin; 2010 Jan; 28(1):55-60. PubMed ID: 19945616
[TBL] [Abstract][Full Text] [Related]
7. In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.
Robbins PB; Lin Q; Goodnough JB; Tian H; Chen X; Khavari PA
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5193-8. PubMed ID: 11296269
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy approaches for epidermolysis bullosa.
Ferrari S; Pellegrini G; Mavilio F; De Luca M
Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of cell line LSV5 that retains the altered adhesive properties of human junctional epidermolysis bullosa keratinocytes.
Miquel C; Gagnoux-Palacios L; Durand-Clement M; Marinkovich P; Ortonne JP; Meneguzzi G
Exp Cell Res; 1996 May; 224(2):279-90. PubMed ID: 8612705
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation.
McMillan JR; McGrath JA; Pulkkinen L; Kon A; Burgeson RE; Ortonne JP; Meneguzzi G; Uitto J; Eady RA
Br J Dermatol; 1997 Jun; 136(6):817-22. PubMed ID: 9217810
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa.
Pulkkinen L; Christiano AM; Airenne T; Haakana H; Tryggvason K; Uitto J
Nat Genet; 1994 Mar; 6(3):293-7. PubMed ID: 8012393
[TBL] [Abstract][Full Text] [Related]
12. Treatment of two patients with Herlitz junctional epidermolysis bullosa with artificial skin bioequivalents.
Jiang QJ; Izakovic J; Zenker M; Fartasch M; Meneguzzi G; Rascher W; Schneider H
J Pediatr; 2002 Oct; 141(4):553-9. PubMed ID: 12378197
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy and the skin.
Hengge UR; Bardenheuer W
Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):93-100. PubMed ID: 15468151
[TBL] [Abstract][Full Text] [Related]
14. Awakening gene therapy with Sleeping Beauty transposons.
Essner JJ; McIvor RS; Hackett PB
Curr Opin Pharmacol; 2005 Oct; 5(5):513-9. PubMed ID: 16084771
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.
Benati D; Miselli F; Cocchiarella F; Patrizi C; Carretero M; Baldassarri S; Ammendola V; Has C; Colloca S; Del Rio M; Larcher F; Recchia A
Mol Ther; 2018 Nov; 26(11):2592-2603. PubMed ID: 30122422
[TBL] [Abstract][Full Text] [Related]
16. Impact of laminin 5 beta3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa.
Robbins PB; Sheu SM; Goodnough JB; Khavari PA
Hum Gene Ther; 2001 Jul; 12(11):1443-8. PubMed ID: 11485635
[TBL] [Abstract][Full Text] [Related]
17. Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa.
Endo M; Zoltick PW; Radu A; Jiang Q; Matsui C; Marinkovich PM; McGrath J; Tamai K; Uitto J; Flake AW
Gene Ther; 2012 May; 19(5):561-9. PubMed ID: 21938019
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa.
Posteraro P; Sorvillo S; Gagnoux-Palacios L; Angelo C; Paradisi M; Meneguzzi G; Castiglia D; Zambruno G
Biochem Biophys Res Commun; 1998 Feb; 243(3):758-64. PubMed ID: 9501007
[TBL] [Abstract][Full Text] [Related]
19. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.
Dellambra E; Vailly J; Pellegrini G; Bondanza S; Golisano O; Macchia C; Zambruno G; Meneguzzi G; De Luca M
Hum Gene Ther; 1998 Jun; 9(9):1359-70. PubMed ID: 9650620
[TBL] [Abstract][Full Text] [Related]
20. BP180 gene delivery in junctional epidermolysis bullosa.
Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
